When will Beam Therapeutics submit a BLA for Risto-cel?
Prediction market on kalshi. If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
Liquidity: $72.85. Resolves: 9/8/2026.